Welcome to our dedicated page for CitroTech SEC filings (Ticker: CITR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
CitroTech Inc. filings document the specialty chemical company’s public-company status, securities registration activity and material corporate events. The record includes registration statements for common stock, disclosures on NYSE American-listed shares, historical financial statements, customer and revenue information, preferred stock and subscription-agreement references, and risk and capital-structure matters tied to its fire inhibitor business.
Material-event filings cover the company’s completed name change from General Enterprise Ventures to CitroTech, outstanding warrant clarifications, executive transition arrangements, and the HexiTech joint venture agreement with Hexion for products incorporating CitroTech fire-retardant intellectual property. The filings also identify CitroTech as a Wyoming corporation and provide governance, agreement and securities details relevant to its reporting obligations.
CitroTech Inc. (CITR) disclosed that it amended its Stock Exchange and Stockholders Agreements with BoltRock Holdings, LLC and TC Special Investments LLC. Each investor no longer has a contractual right to appoint a director; instead, while it and its affiliates hold at least a formula-based percentage of CitroTech’s voting power, it may designate one nominee for election to the board, and in some cases a non-voting board observer. These rights adjust automatically with board size and terminate if the ownership threshold is not met, and remain subject to legal and NYSE American requirements.
CitroTech also furnished an extensive investor presentation describing its citric-acid-based wildfire protection platform, the HexiTech joint venture with Hexion, and its strategy toward federal U.S. Forest Service Qualified Products List access. The presentation reiterates a going concern uncertainty previously disclosed, noting cash of $2.5 million and working capital of $3.0 million as of June 30, 2026, no debt, operating cash use of about $1.0 million per quarter, and a commitment by Hexion of up to $6.0 million for joint-venture capital contributions, while the company evaluates additional financing alternatives.
CitroTech Inc. filed an amendment to its June 30, 2026 quarterly report to add interactive data exhibits and refreshed officer certifications; the underlying second‑quarter 2026 financials remain unchanged. The company develops environmentally sustainable fire‑inhibiting chemicals and systems.
For the six months ended June 30, 2026, CitroTech generated $625,581 in revenue, down from $1,657,020 a year earlier, and recorded a net loss of $10.1 million versus $22.8 million in 2025. Q2 2026 revenue of $280,666 declined 59% year over year, while operating expenses were broadly flat. Significant non‑cash stock‑based compensation and prior‑year financing and derivative charges materially affect comparability.
At June 30, 2026, CitroTech held $2.5 million of cash, working capital of $3.3 million, total assets of $10.0 million, and an accumulated deficit of $123.3 million. Management states that existing cash will not fund commercial‑scale production and related working capital for the next 12 months, and explicitly discloses substantial doubt about the company’s ability to continue as a going concern. Management is evaluating additional equity or debt financing but notes there is no assurance of availability or terms.
CitroTech Inc., a specialty chemical company focused on environmentally friendly fire inhibitors, reported continued losses while restructuring its balance sheet for the quarter ended June 30, 2026. Q2 2026 revenue was $280,666, down 59% from $687,638 a year earlier as project-based system installation work shifted toward a partner-driven, chemical-sales model and there were no repeat of 2025 fire-driven deployments.
Q2 net loss narrowed to $3,902,554 from $11,904,018, helped by a sharp reduction in interest, financing and derivative-related expenses after converting all $2.4 million of convertible notes (including related party) into equity. For the first six months, revenue was $625,581 and net loss was $10,113,118. Cash was $2,519,302 with working capital of about $3.3 million, total assets of $10,036,040 and total liabilities of $1,023,178.
Management disclosed that current cash is not sufficient to fund commercial-scale production for the next 12 months, and stated that these conditions raise substantial doubt about CitroTech’s ability to continue as a going concern. The company is seeking additional equity or debt financing while investing in R&D, certifications and commercialization of its CitroTech formulations, including a new 50/50 joint venture with Hexion Inc. to develop fire-resistant lumber and wood products.
Stephen Conboy reports beneficial ownership of 2,061,669 CitroTech Inc. Common Shares, representing approximately 9.14% of the 22,554,586 Common Shares outstanding, including 1,112 shares issuable upon exercise of warrants.
His position reflects several transactions: conversion of 550,000 Series C Convertible Preferred Shares into 1,833,334 Common Shares on August 22, 2025; purchase of 667 Series C shares for $10,005 at $15.00 per share on September 30, 2025 and their conversion into 2,224 Common Shares on April 16, 2026, together with a warrant covering up to 50% of the related conversion shares. Subsequent activity included a gift of 150,000 Common Shares on July 24, 2026 and the sale of 275,001 Common Shares at $3.00 per share on August 4, 2026.
CitroTech Inc. reported that former Chief Technology Officer Stephen Conboy sold 275,001 shares of common stock at $3.00 per share in an open-market or private transaction. Following this sale, he directly holds 2,060,557 shares of CitroTech common stock.
Stephen Conboy, a ten percent owner of CitroTech Inc., converted 667 shares of Series C Convertible Preferred Stock into 2,224 shares of Common Stock, eliminating his holdings of that preferred class. He also made a bona fide gift of 150,000 Common shares at a reported price of $0.00 per share.
Michael M. Feigin, a director of CitroTech Inc., is reported as holding 161,967 shares of CitroTech common stock, par value $0.0001 per share, directly as of June 17, 2026. These holdings are classified as direct ownership.
CitroTech Inc. reported that directors Theodore Ralston and Jeffery Pomerantz resigned from its board on June 12, 2026, with the company stating their departures did not arise from any dispute with management or the board.
On June 17, 2026, the board appointed Michael Feigin, a 66-year-old executive with more than 35 years of construction and real estate leadership experience, to fill one of the two vacancies. He joins the audit and compensation committees and will chair the nominating and corporate governance committee, receiving standard non‑executive director compensation.
Calinawan Lorenzo reported acquisition or exercise transactions in this Form 4 filing.
CitroTech Inc. director Calinawan Lorenzo received a grant of 41,667 shares of Common Stock on March 16, 2026. The shares were awarded at a stated price of $0.00 per share, indicating a compensation-related equity award rather than a market purchase. Following this grant, Lorenzo directly holds 41,667 shares of CitroTech common stock.
HUFF CRAIG A reported acquisition or exercise transactions in this Form 4 filing.
CitroTech Inc. director and ten percent owner Craig A. Huff received a compensatory grant of 41,667 shares of CitroTech common stock for his service on the board of directors. These new shares are held directly. Separately, 3,357,467 CitroTech shares are held indirectly through BoltRock Holdings LLC, where Huff is the managing member and which may be deemed a director by deputization. Huff disclaims beneficial ownership of the BoltRock-held shares except to the extent of his pecuniary interest.